09/13/2026
You haven't had a in years, and all of sudden you've had three. 😳 And nothing is working. If you are over 35, there is a good chance you are not dealing with just yeast. You are actually likely dealing with a loss of estrogen where it matters and is not received systemically even if you are on HRT.
Start with the tissue itself. Estradiol maintains a thick, hydrated va**nal lining rich in glycogen (a stored form of sugar inside epithelial cells). That glycogen feeds lactobacillus, the dominant protective bacteria of the va**na. These bacteria metabolize glycogen and produce lactic acid, which keeps the va**nal pH in the acidic range of about 3.5 to 4.5.
And that acidity is not just a number, actually it is a defense system. It supports lactobacilli, suppresses harmful bacteria, and helps keep candida, a yeast that often lives there quietly in balance, from becoming invasive or forming biofilm. Estradiol is not just supporting tissue, it is maintaining an entire va**nal and pelvic ecosystem.
When estradiol declines, the whole system begins to change. Glycogen drops, lactobacilli lose their fuel source, and their population falls. Lactic acid production decreases, and the pH rises.
Meanwhile, the tissue becomes thinner, drier, and more fragile. The barrier is weaker, microtears occur more easily, and the immune system is constantly responding to small (and sometimes larger) injury.
And this is when symptoms start to show up. Burning, itching, discharge, discomfort with s*x, a persistent sense that something is wrong. Sensation of grittiness or dryness despite hydration, oils, suppositories, and even treatments for yeast infections! It's often TREATED like a yeast infection because it FEELS and LOOKS like a yeast infection. But symptoms alone are not specific for candida, and many cases, the underlying issue is not "infection" per se. It is the loss of the estrogen-supported environment that used to keep everything stable.
This is SO important to understand!!
And this is not a small group of women. Genitourinary Syndrome of Menopause (GSM) affects the majority of postmenopausal women, with prevalence up to ~84% (NAMS Position Statement 2020).
What this means in practice is that a significant number of women experiencing “recurrent yeast infections” are actually experiencing the effects of estrogen depletion, sometimes with intermittent infection layered on top, but often without confirmed candida at all.
You can often see the difference as well. The tissue may appear paler rather than deep pink. It loses its natural moisture and sheen. There may be a whitish appearance that looks like yeast but is often atrophic change rather than infection.
What has changed is not just hormone levels in the bloodstream. It is the loss of local support within the pelvic tissues. The ovaries were maintaining a regional environment by their presence and activity, and when that signaling fades, the downstream effects show up in the va**na, v***a, urethra, and surrounding structures.
This is why local therapy matters. Estradiol, and in some cases testosterone or DHEA, needs to be present topically at the tissue. When applied locally, glycogen returns, lactobacilli repopulate, lactic acid production increases, pH normalizes, and the tissue becomes resilient again. The ecosystem stabilizes, and symptoms begin to resolve in a way that antifungals alone cannot achieve.
Without restoring that environment, the consequences extend beyond discomfort beyond the va**na. Recurrent urinary tract infections become more common as protective lactobacilli decline and uropathogens colonize more easily. The atrophic tissue becomes less able to ward off infection. Vaginal estrogen reduces recurrent UTIs, with randomized trials showing relative risk reductions of 75%, and some studies demonstrating reductions as high as ~90% (NEJM Raz 1993).
Left unaddressed, these infections are not benign. Women frequently present to the ER with severe infections, urosepsis, delirium, systemic stress, and downstream complications that affect the kidneys, can trigger cardiac events and organ failure.
Once you understand this, you can see that the "yeast infection" being treated over and over again, may not BE a "yeast infection" and may be signaling the need for local estradiol support that is often ignored.
***
Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database of Systematic Reviews. 2008;Issue 2:CD005131.
Raz R, Stamm WE. A controlled trial of intrava**nal estriol in postmenopausal women with recurrent urinary tract infections. New England Journal of Medicine. 1993;329(11):753–756.
The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992.
